➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Dow
Express Scripts
McKesson
Moodys

Last Updated: October 31, 2020

DrugPatentWatch Database Preview

Benzthiazide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for benzthiazide and what is the scope of patent protection?

Benzthiazide is the generic ingredient in five branded drugs marketed by Solvay, Pvt Form, Ah Robins Inc, and Pfizer, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for benzthiazide.

Summary for benzthiazide
US Patents:0
Tradenames:5
Applicants:4
NDAs:4
Drug Master File Entries: 1
Bulk Api Vendors: 42
Patent Applications: 4,487
DailyMed Link:benzthiazide at DailyMed

US Patents and Regulatory Information for benzthiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay AQUATAG benzthiazide TABLET;ORAL 016001-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer FOVANE benzthiazide TABLET;ORAL 012128-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ah Robins Inc EXNA benzthiazide TABLET;ORAL 012489-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pvt Form BENZTHIAZIDE benzthiazide TABLET;ORAL 083206-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay AQUATAG benzthiazide TABLET;ORAL 016001-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer URESE benzthiazide TABLET;ORAL 012128-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKinsey
Express Scripts
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.